Eureka Therapeutics Inc - Company Review
Eureka Therapeutics Inc - Company ReviewSummary
Eureka Therapeutics Inc (Eureka Therapeutics) which focuses on the development of novel T cell immunotherapies for the treatment of solid tumors. Its pipeline encompasses drug candidates for various indications such as liver cancer, hematological cancer, lung cancer, head and cervical cancers, prostate cancer, multiple mylenoma, ovarian and peritoneal cancer, among others. Eureka Therapeutics utilizes its proprietary science platform which enables the discovery of fully-human antibodies against intracellular antigens via the MHC-peptide complex. The company works in academic collaboration with Memorial Sloan-Kettering Cancer Center for the joint discovery and research of new antibodies. Eureka Therapeutics is headquartered in Emeryville, California, the US.
This comprehensive company report of Eureka Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.